A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 16 Issue 2 September 2022) has been published and includes articles on:
Methylphenidate long-acting (modified-release) preparations: caution if switching between products due to differences in formulations
Rucaparib (Rubraca▼): withdrawal of third-line treatment indication
COVID-19 vaccines and medicines: updates for September 2022
Letters and medicine recalls sent to healthcare professionals in August 2022
To see the latest MHRA Drug Safety Updates in full, visit the GOV.uk website.